0 Evaluaciones
ID

28021

Descripción

NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: All visits. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Palabras clave

Versiones (2)
  1. 10/12/17 10/12/17 -
  2. 2/1/18 2/1/18 -
Titular de derechos de autor

Prof. Dr. med. Georg Heß

Subido en

10 de diciembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Adverse events GOAL Trial B-cell Lymphoma NCT02499003

    Inglés

    Adverse events GOAL Trial B-cell Lymphoma NCT02499003

    1 formularios  
    Admininstrative data
    Descripción

    Admininstrative data

    Subject ID
    Descripción

    Subject ID

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    Page
    Descripción

    Page

    Tipo de datos

    integer

    Adverse events
    Descripción

    Adverse events

    No.
    Descripción

    adverse event number

    Tipo de datos

    integer

    AE Term (based on CTCAE 4.0)
    Descripción

    Adverse event

    Tipo de datos

    text

    SAE?
    Descripción

    Serious adverse event

    Tipo de datos

    text

    Study termination
    Descripción

    Study termination

    Tipo de datos

    text

    Start date
    Descripción

    Start date

    Tipo de datos

    date

    Stop date
    Descripción

    Stop date

    Tipo de datos

    date

    Ongoing at End of Treatment?
    Descripción

    Ongoing adverse event at End of Treatment

    Tipo de datos

    boolean

    Max. CTCAE grade
    Descripción

    Maximum CTCAE grade

    Tipo de datos

    integer

    Causality with Obinutuzumab
    Descripción

    Causality with Obinutuzumab

    Tipo de datos

    integer

    Causality with Pixantrone
    Descripción

    Causality with Pixantrone

    Tipo de datos

    integer

    Action taken with Obinutuzumab
    Descripción

    Action taken with Obinutuzumab

    Tipo de datos

    integer

    Action taken with Pixantrone
    Descripción

    Action taken with Pixantrone

    Tipo de datos

    integer

    Treatment given?
    Descripción

    Treatment

    Tipo de datos

    text

    Outcome
    Descripción

    Treatment Outcome

    Tipo de datos

    integer

    I have reviewed the AEs on this page and have assessed them for seriousness, causality, severity and outcome and confirm that, to the best of my knowledge, they accurately reflect the study information obtained for this patient.
    Descripción

    I have reviewed the AEs on this page and have assessed them for seriousness, causality, severity and outcome and confirm that, to the best of my knowledge, they accurately reflect the study information obtained for this patient.

    Data correct?
    Descripción

    Data correct

    Tipo de datos

    boolean

    Date of signature
    Descripción

    Date of signature

    Tipo de datos

    date

    Name of investigator
    Descripción

    Name of investigator

    Tipo de datos

    text

    Volver a la parte superior de la página

    Similar models

    Adverse events GOAL Trial B-cell Lymphoma NCT02499003

    1 formularios
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Admininstrative data
    Subject ID
    Item
    Subject ID
    text
    C2348585 (UMLS CUI [1])
    Page
    Item
    Page
    integer
    Item Group
    Adverse events
    Item
    No.
    integer
    adverse event number
    Code List
    No.
    CL Item
    01 (1)
    CL Item
    02 (2)
    CL Item
    03 (3)
    CL Item
    04 (4)
    CL Item
    05 (5)
    CL Item
    06 (6)
    CL Item
    07 (7)
    CL Item
    08 (8)
    CL Item
    09 (9)
    CL Item
    10 (10)
    Adverse event
    Item
    AE Term (based on CTCAE 4.0)
    text
    Serious adverse event
    Code List
    SAE?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Study termination
    text
    Serious adverse event
    Code List
    Study termination
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Start date
    Item
    Start date
    date
    Stop date
    Item
    Stop date
    date
    Ongoing adverse event at End of Treatment
    Item
    Ongoing at End of Treatment?
    boolean
    Maximum CTCAE grade
    Item
    Max. CTCAE grade
    integer
    Item
    Causality with Obinutuzumab
    integer
    Causality with Obinutuzumab
    Code List
    Causality with Obinutuzumab
    CL Item
    Not related (1)
    CL Item
    Related (2)
    Item
    Causality with Pixantrone
    integer
    Causality with Obinutuzumab
    Code List
    Causality with Pixantrone
    CL Item
    Not related (1)
    CL Item
    Related (2)
    Item
    Action taken with Obinutuzumab
    integer
    Action taken with Obinutuzumab
    Code List
    Action taken with Obinutuzumab
    CL Item
    Unchanged (1)
    CL Item
    Reduced (2)
    CL Item
    Interrupted (3)
    CL Item
    Discontinued (4)
    CL Item
    Not applicable (5)
    Item
    Action taken with Pixantrone
    integer
    Action taken with Obinutuzumab
    Code List
    Action taken with Pixantrone
    CL Item
    Unchanged (1)
    CL Item
    Reduced (2)
    CL Item
    Interrupted (3)
    CL Item
    Discontinued (4)
    CL Item
    Not applicable (5)
    Item
    Treatment given?
    text
    Serious adverse event
    Code List
    Treatment given?
    CL Item
    Yes (Y)
    CL Item
    No (N)
    Item
    Outcome
    integer
    Treatment Outcome
    Code List
    Outcome
    CL Item
    Recovered (1)
    CL Item
    Recovered with sequelae (2)
    CL Item
    Recovering (3)
    CL Item
    Not recovered (4)
    CL Item
    Fatal (5)
    CL Item
    Unknown (6)
    Item Group
    I have reviewed the AEs on this page and have assessed them for seriousness, causality, severity and outcome and confirm that, to the best of my knowledge, they accurately reflect the study information obtained for this patient.
    Data correct
    Item
    Data correct?
    boolean
    Date of signature
    Item
    Date of signature
    date
    Name of investigator
    Item
    Name of investigator
    text
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial